Article
Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19
2020-09-02
Abstract excerpt
A recent estimate suggests that one in five deaths globally are associated with sepsis 1 . To date, no targeted treatment is available for this syndrome, likely due to substantial patient heterogeneity 2,3 and our lack of insight into sepsis immunopathology 4 . These issues are highlighted by the current COVID-19 pandemic, wherein many clinical manifestations of severe SARS-CoV-2 infection parallel bacterial se...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d57d8c95-2ff7-5897-a814-867f374a4682
- DOI
- 10.1101/2020.09.02.280180
